Detailed Pharmaceutical Care Plan for an Elderly Asthmatic Patient

This assignment presents a pharmaceutical care plan for a 70-year-old asthmatic patient. The plan includes a review of the patient's social and medical history, which encompasses conditions like myocardial infarction, stable angina, hypertension, hypercholesteremia, and type 2 diabetes, along with a detailed medication list. The plan assesses the patient's asthma control, inhaler technique, and adherence to medication. The analysis identifies key issues such as poor asthma control and frequent salbutamol use. The assignment proposes a management plan that includes medication review (MUR), counseling on inhaler technique, and monitoring of asthma symptoms. The proposed outcome measures include improved inhaler technique and asthma control, with follow-up plans involving regular health checks and annual reviews. References to relevant literature are also provided. The goal is to ensure optimal medication management and improve the patient's quality of life.

Pharmaceutical Care Plan for
an Asthmatic Patient

Reason for Patient Selection and Aims in
Managing this Patient
 Elderly asthmatic patient Opportunistic Medicines Use Review (MUR)
 Ensure optimal medicines management
 Check his understanding of medicines prescribed
 Check medicines adherence and if any side effects
 Check appropriate monitoring
 Ensure patient has no unresolved questions

Patient Social and Medical History
 70 year old married male
 Non-smoker
 BMI 23.7 normal
 Alcohol 5-6 units week
 Diet – Plenty of fruit and veg,
 Impression- old age man suffering from asthma

Medical Conditions and Drug History
 Myocardial infraction MI (2017)
 Stable angina
 Hypertension
 Hyper cholesteremia
 Type 2 diabetes
Medication List Dose Freq Route Start Date Stop Date
Aspirin 100 mg 1 tablet
regular
Oral 2015 Ongoing
Atenolol 25 mg 1 tablet
regular
Oral 2016 Ongooing
Furosemide 40 gm When
needed
Oral 2012 Ongoing
Pavastatin 40gm 1 tablet in
week
Oral 2010 Ongoing

Tests, Observations and Investigations
Monitoring Plan
Parameter Justification Frequency Result(s) and Action Plan
BP monitoring It is done to maintain diabetes level Regular The BP is 85/50
Asthma control The symptoms can led to asthma
attack
During every
health check up
The SpO2 94% RA
Inhaler Technique Ineffective inhaler technique can
result in asthma attack
During every
health check up
In 2 weeks it will be checked

Care Issue Outline
Analysis of Clinical Problems
Clinical Problem Assessment Priority Action Taken and
Outcome
Salbutamol frequent use Poor asthma control Medium It is important in
reducing salbutamol use
Inhaler technique This will affect in
controlling of asthma
High It can improve inhaler
technique
Asthma control By checking it using
ACT
High Score is 15 that is
asthma is not controlled
properly

Pharmaceutical Issue Plan and Proposed
Outcome Measures
Identified Issue Action Taken Proposed Outcome Measure
Clenil non-adherence and
Salbutamol frequent use
MUR Inhaler Technique Check Check technique and change it if
it is poor.
Poor inhaler technique Counselled patient on inhaler
technique
Inspiratory flow rate should be
between 25-60l/min if not
consider GP referral spacer or
change of device e.g. MDI to
DPI- patient preference
ACT Score 17 indicated lack of
asthma symptom control
Discussed inhaler adherence
importance and counselled on
inhaler technique
If ACT still below 20 refer to
doctor

Patient Management Appraisal
 Levothyroxine 50/25 mcg- Hypothyroidism Standard Treatment- Salbutamol/ Clenil –
Asthma – stage 3 follow guidelines strictly.
 Risk of asthma attack and low ACT score
 MUR conducted
 If no improvement within 2 weeks than consult doctor

Follow-Up Plan
 Weekly diabetes check.
 Check asthma in every health check up.
 Annual flu vaccination available from GP or pharmacy
 Annual MUR or advise patient return to pharmacy if symptoms not managed or any concerns.
 Monitor asthma and GTN

REFERENCES
Books and journals
 Ibrahim, H. and Murphy, D.M., 2019. The effectiveness of reslizumab in severe asthma treatment: a
real-world experience. Respiratory research, 20(1), pp.1-5.
 Amaral-Machado, L., 2020. Use of natural products in asthma treatment. Evidence-Based
Complementary and Alternative Medicine, 2020.
 Jabeen, U. and Rathore, A.W., 2018. Adherence to asthma treatment and their association with asthma
control in children. J Pak Med Assoc, 68(5), p.4.

THANK YOU